Endothelial apoptosis triggered by
oxidized low-density lipoprotein (
oxLDL) can accelerate the progression of endothelial dysfunction
atherosclerosis.
Phosphocreatine (PCr) is a natural compound, which has been used in
cardiac disease and
cardiopulmonary resuscitation. However, its protective effects on
atherosclerosis and its mechanism have not been clarified. In the present study, we investigated the anti-apoptotic effect of
phosphocreatine in human umbilical vein endothelial cells (HUVECs) exposed to
oxLDL and explored the possible mechanisms. HUVECs were pre-treated with 10-30 mM PCr and then stimulated with
oxLDL. Cell morphology, cytotoxicity and apoptosis were evaluated by light microscopy, CCK assay, and flow cytometry respectively. Levels of Bax, Bcl-2,
protein expression of
protein kinase B (Akt), eNOS and
caspase activities were assessed by Western blotting.
Reactive oxygen species (ROS) and mitochondrial membrane potential (
MMP) were measured with
fluorescent probes.
Lactate dehydrogenase (LDH),
malondialdehyde (MDA),
nitric oxide (NO) and
superoxide dismutase (SOD) contents were determined by spectrophotometer. Our results showed that PCr dose-dependently prevented
oxLDL associated HUVEC cytotoxicity and apoptotic biochemical changes such as loss of
MMP, LDH and MDA leakage and loss of SOD, decrease of Bcl-2/
Bax protein ratio, activation of
caspase-3 and 9, and ROS generation. In addition, the antiapoptotic effect of PCr was partially inhibited by a PI3K inhibitor (
LY294002) and also enhanced p-Akt/Akt
protein ratio, eNOS activation and NO production. In conclusion, our data show that the inhibition of
oxLDL-induced endothelial apoptosis by PCr is due, at least in part to its
anti-oxidant activity and its ability to modulate the PI3K/Akt/eNOS signaling pathway.